• BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 08 Feb 2025 02:11:10   America/New_York


    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Shares of BioMarin Pharmaceutical Inc.
    Read more...
Share on,